Poisoning by synthetic cannabinoids, self-harm, subs

This code signifies a patient presenting with adverse effects from intentionally self-administering synthetic cannabinoids, and this encounter is for follow-up care after the initial treatment. The patient deliberately ingested or otherwise exposed themselves to these substances with the intent to cause harm. This code is used when the patient is seen for ongoing management of the poisoning's sequelae.

Apply this code when a patient is seen for a subsequent visit related to a previous intentional self-poisoning with synthetic cannabinoids. This includes appointments for monitoring organ damage, managing persistent psychological effects, or addressing complications that arise after the initial acute phase. It is appropriate for follow-up care after discharge from an emergency department or inpatient stay for the initial poisoning event.

• Ensure documentation clearly states "intentional self-harm" and that the substance involved was a "synthetic cannabinoid."
• Confirm the encounter is for follow-up care (e.g., "subsequent encounter") and not the initial acute treatment.
• Always sequence this code after the primary diagnosis related to the specific manifestations of the poisoning (e.g., delirium, cardiac arrhythmia).